Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer risk--does anyone really care?

A R Gregory1

  • 1TECHTO Enterprises, Sterling, Virginia 22170.

Regulatory Toxicology and Pharmacology : RTP
|June 1, 1992
PubMed
Summary

Protecting the public from carcinogens requires validated models. Current cancer testing lacks positive controls, leaving regulatory efforts insufficient to assess real-world risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Poisoning of livestock in oregon in the 1940s to 1960s attributed to corynetoxins produced by Rathayibacter in nematode galls in chewings fescue (Festuca nigrescens).

Veterinary and human toxicology·2003
Same author

Comparative immunogenicity of two bivalent botulinum vaccines.

Australian veterinary journal·2000
Same author

Sequence data suggests big liver and spleen disease virus (BLSV) is genetically related to hepatitis E virus.

Veterinary microbiology·1999
Same author

Human papillomavirus DNA and virus-encoded antigens in cervical carcinoma.

The Medical journal of Malaysia·1997
Same author

Use of enzyme-linked immunoassays for antibody to types C and D botulinum toxins for investigations of botulism in cattle.

Australian veterinary journal·1996
Same author

Serological diagnosis of botulism in dairy cattle.

Australian veterinary journal·1996

Area of Science:

  • Toxicology
  • Carcinogenesis Research
  • Regulatory Science

Background:

  • Despite numerous laws, effective public protection from carcinogens remains elusive.
  • Current regulatory approaches rely on epidemiology and unverified bioassay models, which are insufficient for risk assessment.

Purpose of the Study:

  • To highlight the critical need for validated carcinogenicity models.
  • To emphasize the necessity of using positive controls (known human carcinogens) in cancer testing.
  • To advocate for risk assessment models that provide quantitative estimates of human cancer risk.

Main Methods:

  • Critique of current epidemiological and bioassay methodologies in carcinogen testing.
  • Analysis of the limitations in existing cancer testing facilities, specifically the absence of positive controls.
  • Discussion on the requirements for effective carcinogenicity models.

Main Results:

  • Existing cancer testing facilities lack validation through positive controls, hindering accurate risk assessment.
  • Current methods cannot reliably determine if a substance poses a reasonable risk of carcinogenesis in humans.
  • The absence of validated models means regulatory efforts, despite legislative action, fail to protect the public.

Conclusions:

  • Validated models are essential for accurate carcinogen risk assessment.
  • The integration of positive controls in cancer testing is crucial for validating results.
  • Effective public protection from carcinogens necessitates a shift towards scientifically rigorous and validated testing methodologies.

Related Experiment Videos